packageElacestrant

elacestrant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Elacestrant is an anti-estrogen medicine used to treat breast cancer. It is an approved drug and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q27278069 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:elacestrant
ATC codes:L02BA04
DrugBank:DB06374
PubChem CID:23642301
Wikidata:Q27278069
formula:C30H38N2O2
molar mass:458.646 g/mol (PubChem CID 23642301)
logP:6.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown